Report Categories
View AllRecent Articles
View All
SVAQ Silicon management details strategic merger search plans to deliver strong shareholder value over coming quarters
Why Netskope NTSK leadership matters more than you think Pulls Back 20260511
CTS Corp CTS Stock Is It a Strong Buy 017 20260420
RGNT Regentis Biomaterials outlines key orthopedic product growth priorities in latest quarterly earnings update
MTD MettlerToledo International posts Q4 2025 earnings beat and 4 percent revenue growth yet shares fall 107 percent
BELFA Bel Fuse shares climb 605 percent after Q1 2026 earnings per share beat analyst projections
The growth story Westport WPRT is not telling investors Trend Weakens 20260508
What would it take for National NPK to double from here On the Radar 20260506
Is Hoth Therapeutics HOTH a once in a decade opportunity Weakens 20260508
Protalix PLX Q1 2026 Earnings Beat Revenue NA EPS 022
Black Titan BTTC Stock Today Drops 391 Key Support at 117 20260517
Deckers DECK Drops 179 Key Support at 8861 20260515
Revelation Biosciences REVB Q1 2026 Results Fall Short EPS 271 Revenue NA
XRN Q1 2026 Earnings Disappointing EPS Miss but Stock Rises 331
Samsung Faces Potential Strike as 48000 Workers Demand Bonus Changes
Princeton Digital Groups 1bn Sale Marks Final Exit of Global Buyout Funds from Chinas Data Centres
Host HST Q1 2026 Earnings EPS 072 Beats Estimates
IPW Q3 2025 Earnings EPS Misses Estimates Amidst Revenue Disclosure Gap Stock Slides 82
TRINI Q1 2026 Earnings EPS Beats Estimates as Net Investment Income Holds Steady
NUWE Q1 2026 Earnings EPS Misses Estimates Sharply Stock Rises 537
ADAMZ Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat Despite Modest Share Decline
Sera Prognostics Q1 2026 Earnings EPS In Line with Estimates as Stock Rises 15
NeOnc Technologies NTHI Edges Lower but Holds Above Key Support as Trading Volume Remains Subdued
Arvinas Inc ARVN Consolidates Near Support Amid Low Volatility
DTE Energy Junior Subordinated Debentures DTW Hold Steady as Interest Rate Uncertainty Lingers
Seres Therapeutics MCRB Edges Higher Amid Steady Support and Resistance Dynamics